UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
|
July 1, 2004 | |
Pharmion Corporation
| Delaware | 000-50447 | 84-1521333 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 2525 28th Street, Boulder, Colorado | 80301 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code
|
720-564-9100 | |
| Item 5. Other Events and Regulation FD Disclosure | ||||||||
| Item 7. Financial Statements, Pro Forma Financial Information And Exhibits | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Press Release | ||||||||
Item
|
5. | Other Events and Regulation FD Disclosure | ||||
| On July 1, 2004, Pharmion Corporation, a Delaware corporation (the “Company”), issued a press release announcing that it has priced its previously announced offering of common stock. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. |
Item
|
7. | Financial Statements, Pro Forma Financial Information And Exhibits | ||||
| (c) Exhibits | ||||||
| 99.1 Press Release, dated July 1, 2004, entitled “Pharmion Corporation Announces Pricing of Offering of Common Stock.” |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHARMION CORPORATION | ||||
| Date: July 1, 2004 | By: | /s/ Erle T. Mast Erle T. Mast Chief Financial Officer |
||
3